Pharmacokinetics and Pharmacodynamics of Peptide and Protein Drugs

about

Population pharmacokinetics of cetuximab in patients with squamous cell carcinoma of the head and neck.Pharmacokinetics and Half-Life of Protein Therapeutics Pharmacokinetics and Pharmacodynamics of Therapeutic Peptides and Proteins

P2860

Q51896176-3D9F3D0B-FC87-4F8D-B513-92FE1B798420 Q58869604-90DCCED6-3E34-4803-A644-730B8CFBC57E Q58869607-EAF0C4E3-0BD2-4EE6-8EE7-48DF7B13C8FE

P2860

Pharmacokinetics and Pharmacodynamics of Peptide and Protein Drugs

Item

http://www.wikidata.org/entity/Q58869645

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2007

@uk

name

Pharmacokinetics and Pharmacodynamics of Peptide and Protein Drugs

@en

Pharmacokinetics and Pharmacodynamics of Peptide and Protein Drugs

@nl

type

Item

label

Pharmacokinetics and Pharmacodynamics of Peptide and Protein Drugs

@en

Pharmacokinetics and Pharmacodynamics of Peptide and Protein Drugs

@nl

prefLabel

Pharmacokinetics and Pharmacodynamics of Peptide and Protein Drugs

@en

Pharmacokinetics and Pharmacodynamics of Peptide and Protein Drugs

@nl

P1476

Pharmacokinetics and Pharmacodynamics of Peptide and Protein Drugs

@en

P2093

Bernd Meibohm

http://www.w3.org/2001/XMLSchema#string

Rene Braeckman

http://www.w3.org/2001/XMLSchema#string

P2860

A regulatory perspective on pharmacokinetic/pharmacodynamic modelling.

Optimizing the science of drug development: opportunities for better candidate selection and accelerated evaluation in humans.

Pharmacokinetic/pharmacodynamic studies in drug product development.

Epidermal growth factor receptors as a target for cancer treatment: the emerging role of IMC-C225 in the treatment of lung and head and neck cancers.

Pharmacokinetics of pegfilgrastim.

Characteristics of indirect pharmacodynamic models and applications to clinical drug responses.

Target-mediated drug disposition and dynamics.

The renal metabolism of insulin.

Kinetics of pharmacologic response.

Effects of route and formulation on clinical pharmacokinetics of interleukin-2.

P304

95-123

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/9781420044386-6

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime